TNF and glioblastoma: Moreover, the transcriptomic data also showed significant enrichment of pathways associated with immune responses, including interferon alpha, interferon gamma, complement, inflammatory response, and TNF-α signaling, thus highlighting potential immunotherapy potential of this drug combination via immunogenic cell death of GBM cells [60]—which typically has an immunologically “cold” microenvironment [61].